Liminal BioSciences' IFRS net income for 2021 was C$12.213 million, compared to a loss of C$118.757 million in the previous year. Revenue decreased 11.2% to C$643,000 from C$724,000 a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept